viability assays human colon cancer cell lines sw620 Search Results


human crc cell lines  (ATCC)
98
ATCC human crc cell lines
Rg3 represses the growth and migration of colorectal cancer <t>(CRC)</t> cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition <t>on</t> <t>LoVo,</t> SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.
Human Crc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viability+assays+human+colon+cancer+cell+lines+sw620/SW620/pmc05743384-85-1-13
Average 98 stars, based on 1 article reviews
human crc cell lines - by Bioz Stars, 2026-09
98/100 stars
  Buy from Supplier
sw620 human tumour cells  (AstraZeneca ltd)
90
AstraZeneca ltd sw620 human tumour cells
Rg3 represses the growth and migration of colorectal cancer <t>(CRC)</t> cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition <t>on</t> <t>LoVo,</t> SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.
Sw620 Human Tumour Cells, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viability+assays+human+colon+cancer+cell+lines+sw620/sw620+human+tumour+cells/us10577351-1145-34-15
Average 90 stars, based on 1 article reviews
sw620 human tumour cells - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human colorectal adenocarcinoma  (ATCC)
96
ATCC human colorectal adenocarcinoma
Rg3 represses the growth and migration of colorectal cancer <t>(CRC)</t> cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition <t>on</t> <t>LoVo,</t> SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.
Human Colorectal Adenocarcinoma, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viability+assays+human+colon+cancer+cell+lines+sw620/SW620%3B+Colon+Adenocarcinoma%3B+Human/pmc03238347-71-43-46
Average 96 stars, based on 1 article reviews
human colorectal adenocarcinoma - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier
sw620 human colorectal cancer cell line  (BioResource International Inc)
90
BioResource International Inc sw620 human colorectal cancer cell line
Rg3 represses the growth and migration of colorectal cancer <t>(CRC)</t> cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition <t>on</t> <t>LoVo,</t> SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.
Sw620 Human Colorectal Cancer Cell Line, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viability+assays+human+colon+cancer+cell+lines+sw620/sw480/pm23577199-147-6-20
Average 90 stars, based on 1 article reviews
sw620 human colorectal cancer cell line - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human colorectal cancer crc cell lines  (ATCC)
95
ATCC human colorectal cancer crc cell lines
Rg3 represses the growth and migration of colorectal cancer <t>(CRC)</t> cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition <t>on</t> <t>LoVo,</t> SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.
Human Colorectal Cancer Crc Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viability+assays+human+colon+cancer+cell+lines+sw620/SW1116/pmc04703732-143-0-16
Average 95 stars, based on 1 article reviews
human colorectal cancer crc cell lines - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier
sw620  (OriGene)
90
OriGene sw620
Rg3 represses the growth and migration of colorectal cancer <t>(CRC)</t> cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition <t>on</t> <t>LoVo,</t> SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.
Sw620, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viability+assays+human+colon+cancer+cell+lines+sw620/SW620+(Human+Colon+Adenocarcinoma)+Whole+Cell+Lysate/pmc11072676-90-7-16
Average 90 stars, based on 1 article reviews
sw620 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
leibovitz l 15 medium boster  (Danaher Inc)
93
Danaher Inc leibovitz l 15 medium boster
Rg3 represses the growth and migration of colorectal cancer <t>(CRC)</t> cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition <t>on</t> <t>LoVo,</t> SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.
Leibovitz L 15 Medium Boster, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viability+assays+human+colon+cancer+cell+lines+sw620/Leibovitz+L-15+with+L-glutamine/pmc07807274-187-6-5
Average 93 stars, based on 1 article reviews
leibovitz l 15 medium boster - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
human colorectal cancer cell lines  (Procell Inc)
86
Procell Inc human colorectal cancer cell lines
Rg3 represses the growth and migration of colorectal cancer <t>(CRC)</t> cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition <t>on</t> <t>LoVo,</t> SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.
Human Colorectal Cancer Cell Lines, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/viability+assays+human+colon+cancer+cell+lines+sw620/cells+hepg2/pm41749316-75-0-25
Average 86 stars, based on 1 article reviews
human colorectal cancer cell lines - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


Rg3 represses the growth and migration of colorectal cancer (CRC) cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition on LoVo, SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.

Journal: International Journal of Oncology

Article Title: Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo

doi: 10.3892/ijo.2017.4183

Figure Lengend Snippet: Rg3 represses the growth and migration of colorectal cancer (CRC) cells. (A) Exposure to various concentrations of Rg3 resulted in a dose- and time-dependent growth inhibition on LoVo, SW620 and HCT116 CRC cells. (B) Treatment with 200 μ M Rg3 resulted in time-dependent inhibition on the migration of LoVo and SW620 cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.

Article Snippet: The human CRC cell lines, LoVo, SW620 and HCT116, were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA).

Techniques: Migration, Inhibition, Control

Rg3 represses the stemness of colorectal cancer (CRC) cells. (A) Rg3 repressed the expressions of CD24, CD44 and EpCAM at the mRNA level in LoVo cells. Cells were treated with 200 μ M Rg3 and mRNA expressions were determined using real-time PCR. (B–D) Rg3 reducd the levels of CD24 (B), CD44 (C) and EpCAM (D) proteins in LoVo cells. Cells were treated with 200 μ M Rg3 and protein levels were evaluated using flow cytometry. (E) Rg3 treatment (200 μ M) decreased the population of CD24 + /CD44 + /EpCAM + cells among LoVo cells. (F and G) Rg3 treatment inhibited the clone formation ability of LoVo (F) and HCT116 (G) cells in a dose-dependent manner. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.

Journal: International Journal of Oncology

Article Title: Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo

doi: 10.3892/ijo.2017.4183

Figure Lengend Snippet: Rg3 represses the stemness of colorectal cancer (CRC) cells. (A) Rg3 repressed the expressions of CD24, CD44 and EpCAM at the mRNA level in LoVo cells. Cells were treated with 200 μ M Rg3 and mRNA expressions were determined using real-time PCR. (B–D) Rg3 reducd the levels of CD24 (B), CD44 (C) and EpCAM (D) proteins in LoVo cells. Cells were treated with 200 μ M Rg3 and protein levels were evaluated using flow cytometry. (E) Rg3 treatment (200 μ M) decreased the population of CD24 + /CD44 + /EpCAM + cells among LoVo cells. (F and G) Rg3 treatment inhibited the clone formation ability of LoVo (F) and HCT116 (G) cells in a dose-dependent manner. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.

Article Snippet: The human CRC cell lines, LoVo, SW620 and HCT116, were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA).

Techniques: Real-time Polymerase Chain Reaction, Flow Cytometry, Control

Rg3 represses growth and stemness of colorectal cancer (CRC) cells in vivo . (A) Images of resected LoVo and SW620 orthotopic xenografts. Mice bearing LoVo or SW620 orthotopic xenografts were randomly divided into two groups (five mice in each group): The Rg3 group, which received Rg3 by gastric perfusion daily (25 mg/kg) for 12 consecutive days, and the control group, which was treated with normal saline. (B) Tumor weights of resected LoVo and SW620 orthotopic xenografts. (C–J) Immunohistochemical examination of Ki-67 (C and D), CD24 (E and F), CD44 (G and H) and EpCAM (I and J) levels in LoVo and SW620 orthotopic xenografts. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.

Journal: International Journal of Oncology

Article Title: Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo

doi: 10.3892/ijo.2017.4183

Figure Lengend Snippet: Rg3 represses growth and stemness of colorectal cancer (CRC) cells in vivo . (A) Images of resected LoVo and SW620 orthotopic xenografts. Mice bearing LoVo or SW620 orthotopic xenografts were randomly divided into two groups (five mice in each group): The Rg3 group, which received Rg3 by gastric perfusion daily (25 mg/kg) for 12 consecutive days, and the control group, which was treated with normal saline. (B) Tumor weights of resected LoVo and SW620 orthotopic xenografts. (C–J) Immunohistochemical examination of Ki-67 (C and D), CD24 (E and F), CD44 (G and H) and EpCAM (I and J) levels in LoVo and SW620 orthotopic xenografts. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.

Article Snippet: The human CRC cell lines, LoVo, SW620 and HCT116, were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA).

Techniques: In Vivo, Control, Saline, Immunohistochemical staining

Rg3 represses angiogenesis of colorectal cancer (CRC). (A) Immunohistochemical examination of LoVo and SW620 orthotopic xenografts using an anti-CD34 antibody. (B) Rg3 treatment decreased the microvessel density (MVD) levels in both LoVo and SW620 orthotopic xenografts. (C) Real-time PCR showing that Rg3 downregulated the expression of angiogenesis-related genes in LoVo cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.

Journal: International Journal of Oncology

Article Title: Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo

doi: 10.3892/ijo.2017.4183

Figure Lengend Snippet: Rg3 represses angiogenesis of colorectal cancer (CRC). (A) Immunohistochemical examination of LoVo and SW620 orthotopic xenografts using an anti-CD34 antibody. (B) Rg3 treatment decreased the microvessel density (MVD) levels in both LoVo and SW620 orthotopic xenografts. (C) Real-time PCR showing that Rg3 downregulated the expression of angiogenesis-related genes in LoVo cells. * P<0.05 and ** P<0.01 indicate significant differences compared with the respective control groups.

Article Snippet: The human CRC cell lines, LoVo, SW620 and HCT116, were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA).

Techniques: Immunohistochemical staining, Real-time Polymerase Chain Reaction, Expressing, Control

Rg3 downregulates the levels of B7-H1 and B7-H3 in colorectal cancer (CRC). (A and B) Immunohistochemical examinations of B7H1 (A) and B7H3 (B) levels in human CRC tissue samples. (C and D) Kaplan-Meier curves for CRC overall survival according to tumor B7-H1 (C) and B7-H3 (D) expression status (low vs. high, P<0.01). (E and F) Immunohistochemical examination of B7H1 (E) and B7H3 (F) levels in LoVo orthotopic xenografts after Rg3 treatment.

Journal: International Journal of Oncology

Article Title: Ginsenoside Rg3 targets cancer stem cells and tumor angiogenesis to inhibit colorectal cancer progression in vivo

doi: 10.3892/ijo.2017.4183

Figure Lengend Snippet: Rg3 downregulates the levels of B7-H1 and B7-H3 in colorectal cancer (CRC). (A and B) Immunohistochemical examinations of B7H1 (A) and B7H3 (B) levels in human CRC tissue samples. (C and D) Kaplan-Meier curves for CRC overall survival according to tumor B7-H1 (C) and B7-H3 (D) expression status (low vs. high, P<0.01). (E and F) Immunohistochemical examination of B7H1 (E) and B7H3 (F) levels in LoVo orthotopic xenografts after Rg3 treatment.

Article Snippet: The human CRC cell lines, LoVo, SW620 and HCT116, were purchased from the American Type Culture Collection (ATCC; Manassas, VA, USA).

Techniques: Immunohistochemical staining, Expressing